AlzChem Group (XTRA:ACT0) Stock Sees Fair Value Cut As Analysts Trim Targets
The latest revision for AlzChem Group cuts the stated Fair Value from €205.81 to €182.33, pointing to a lower implied equity value than before. Analysts are keeping a mix of optimi…